Last reviewed · How we verify

NCT04928872

Macronutrient Distribution and Plasma Metabolites to Model Meals Composition

Completed Last updated 21 February 2022
What this trial tests

trial testing Predefined meal in Glucose Metabolism in 23 participants. Completed in 14 January 2020.

Timeline
20 June 2018
Primary endpoint
14 January 2020
14 January 2020

Quick facts

Lead sponsorTexas A&M University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment23
Start date20 June 2018
Primary completion14 January 2020
Estimated completion14 January 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Texas A&M University

Who can join

Adults 60 to 85, any sex, with Glucose Metabolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Continuous glucose monitors (CGMs) measure plasma glucose concentration continually and thus they are a key tool in the management of diabetes, including type 2 diabetes (T2D). A key factor in diabetes management is a reduction of dietary carbohydrates (CHO) and/or exchanging high glycemic index (GI) CHO with low GI CHO. However, the protein and fat content of the meal can have a significant impact on the glucose readings obtained from a CGM as there is no enough data available on their sensitivity during meals.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Abdominal obesity in COPD is associated with specific metabolic and functional phenotypes.
    Cruthirds CL, Deutz NEP, Mizubuti YGG, Harrykissoon RI, et al · · 2022 · cited 11× · PMID 36457012 · DOI 10.1186/s12986-022-00714-z
  2. Discordance between postprandial plasma glucose measurement and continuous glucose monitoring.
    Barua S, A Wierzchowska-McNew R, Deutz NEP, Sabharwal A. · · 2022 · cited 7× · PMID 35776949 · DOI 10.1093/ajcn/nqac181
  3. Estimating Breakfast Characteristics Using Continuous Glucose Monitoring and Machine Learning in Adults With or at Risk of Type 2 Diabetes.
    Pai R, Barua S, Kim BS, McDonald M, et al · · 2026 · cited 5× · PMID 39311452 · DOI 10.1177/19322968241274800
  4. Whole-body and intracellular arginine metabolism in hypertension: role of disease severity and sex.
    Hüttl VN, Deutz N, Wierzchowska-McNew RA, Ruebush LE, et al · · 2026 · PMID 42149813 · DOI 10.1093/ajh/hpag047

Verify or expand the search:

Other recruiting trials for Glucose Metabolism

Currently open trials in the same condition.

Other Texas A&M University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04928872.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing